GBX up +1.85% percent right now. $GBX High is at 61.75 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 2:23 PM

GBX up +1.85% percent right now. $GBX High is at 61.75 and the Low 60.00 with current volume of 284,185.

Recent News posted below.

GBX Greenbrier Companies Recent Headline News

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Greenbrier Cos Is Down 1.4% (GBX)
Comtex SmarTrend(R) - 2 hrs 4 mins ago
11 days ago, on October 30th, 2014, Greenbrier Cos (NYSE:GBX) reported its earnings. Analysts, on average, expected earnings of $1.02 per share on sales of $626.5 million. The company actually reported EPS of $1.03 on sales of $618.1 million, beating EPS estimates by $0.01 and missing revenue estimates by $8.4 million. Since the company's report, shares of Greenbrier Cos have fallen from $60.74 to $59.91, representing a loss of 1.4% in the past 11 days.
GBX: 61.09 (+1.18)

The Zacks Analyst Blog Highlights: Railcar Industries, Greenbrier, Trinity Industries and GATX
PR Newswire - Mon Nov 10, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Railcar Industries, Inc. (Nasdaq:ARII-Free Report), Greenbrier Companies, Inc. (NYSE:GBX-Free Report), Trinity Industries Inc. (NYSE:TRN-Free Report) and GATX Corp. (NYSE:GMT-Free Report).
GBX: 61.09 (+1.18), TRN: 35.85 (+0.15)

Railcar Demand Defies Oil Slide: 4 Stock Picks - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Nov 07, 9:22AM CST
The demand for railroad tank-car orders continues to grow despite the decline in oil prices.
ARII: 68.70 (+2.42), GMT: 65.39 (+0.28), GBX: 61.09 (+1.18), TRN: 35.85 (+0.15)

Greenbrier to webcast presentation at the Stephens 2014 Fall Investment Conference
PR Newswire - Wed Nov 05, 7:14PM CST
The Greenbrier Companies, Inc. (NYSE:GBX) will be presenting on Wednesday, November 12, 2014, at the Stephens 2014 Fall Investment Conference to be held in New York, NY.
GBX: 61.09 (+1.18)

Sanmina Corporation (SANM) & The Greenbrier Companies (GBX): This Week's Value Stock Picks - Video Blog
Tracey Ryniec - Zacks Investment Research - Tue Nov 04, 3:31PM CST
Value stock strategist, Tracey Ryniec, discusses Sanmina (SANM) and The Greenbrier Companies (GBX)
GBX: 61.09 (+1.18), SANM: 25.35 (-0.25)

Zacks' Bull Of The Day: Greenbrier
Zacks Investment Research - at Seeking Alpha - Tue Nov 04, 2:11PM CST
The price of oil and other commodities may be lower, but it sure doesn't mean that the US is moving any less of the stuff across the country on the rails. And for that, you need a continuous supply of industrial-strength freight cars that meet the...
GBX: 61.09 (+1.18), TRN: 35.85 (+0.15)

Greenbrier, Baker Hughes, Time Warner, Best Buy and L Brands highlighted as Zacks Bull and Bear of the Day
PR Newswire - Tue Nov 04, 8:30AM CST
Zacks Equity Research highlights Greenbrier Companies (NYSE:GBX-Free Report) as the Bull of the Day and Baker Hughes (NYSE:BHI-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Time Warner Inc. (NYSE:TWX-Free Report), Best Buy Co., Inc. (NYSE:BBY-Free Report)and L Brands, Inc. (NYSE:LB-Free Report).
LB: 76.04 (+0.43), GBX: 61.09 (+1.18), BBY: 34.79 (-0.39)

Bull of the Day: Greenbrier (GBX) - Bull of the Day
Kevin Cook - Zacks Investment Research - Tue Nov 04, 1:27AM CST
Bull of the Day: Greenbrier (GBX) - Bull of the Day
GBX: 61.09 (+1.18), TRN: 35.85 (+0.15)

Greenbrier Cos Has Returned 9.2% Since SmarTrend Recommendation (GBX)
Comtex SmarTrend(R) - Mon Nov 03, 4:50PM CST
SmarTrend identified an Uptrend for Greenbrier Cos (NYSE:GBX) on October 17th, 2014 at $55.94. In approximately 2 weeks, Greenbrier Cos has returned 9.24% as of today's recent price of $61.11.
GBX: 61.09 (+1.18)

The Greenbrier Companies' (GBX) CEO William Furman on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:01PM CDT

GBX: 61.09 (+1.18)

The Greenbrier Companies (GBX) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:55AM CDT

GBX: 61.09 (+1.18)

Greenbrier beats 4Q profit forecasts
Automated Insights - Thu Oct 30, 5:36AM CDT
LAKE OSWEGO, Ore. (AP) _ Greenbrier Companies Inc. (GBX) on Thursday reported earnings of $47.4 million in its fiscal fourth quarter.
GBX: 61.09 (+1.18)

Greenbrier EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:12AM CDT

GBX: 61.09 (+1.18)

Greenbrier Reports Record Results for Fourth Quarter and Fiscal Year; Backlog Grows to Record 31,500 units
PR Newswire - Thu Oct 30, 5:00AM CDT
The Greenbrier Companies, Inc. (NYSE: GBX) today reported financial results for its fourth fiscal quarter and full year ended August 31, 2014.
GBX: 61.09 (+1.18)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 58.48 (+0.10), HST: 22.83 (+0.17), CRR: 50.15 (-1.05), CAH: 78.91 (+0.64), AMT: 98.95 (-0.52), ACIW: 18.49 (-0.03), GTI: 4.36 (-0.13), IDA: 62.70 (+0.15), CRCM: 8.47 (-0.09), CVRR: 23.07 (-0.74), BGCP: 8.50 (+0.02), GOV: 23.29 (+0.11), DFT: 31.15 (+0.56), APO: 23.68 (+0.30), FIG: 7.33 (+0.01), AMAG: 34.64 (-0.31), HAR: 107.60 (+0.52), AVP: 10.44 (-0.14), EXLS: 28.68 (-0.01), INGR: 79.91 (+0.07), ALU: 3.15 (-0.17), INCY: 69.94 (+0.62), COP: 71.59 (-0.57), GEL: 49.38 (-0.21), COR: 37.89 (+0.09), GTLS: 45.80 (-1.15), BWA: 56.55 (-1.13), CARB: 11.01 (-0.04), GLOP: 26.25 (+0.09), IDCC: 49.49 (-0.09), HEES: 38.16 (-0.21), BCO: 21.56 (+0.05), DST: 99.22 (+0.03), EPD: 37.73 (+0.11), ABMD: 32.84 (+0.71), CEVA: 15.79 (-0.01), BLL: 65.54 (+0.57), GBX: 61.09 (+1.18), GNC: 42.82 (-0.24), CVI: 47.95 (-0.96), ACOR: 35.73 (+0.62), I: 18.30 (-0.31), FCN: 40.94 (+0.21), CRNT: 1.16 (-0.01), DHX: 10.83 (+0.30), BG: 88.90 (+0.14), CME: 85.77 (+0.17), FCH: 10.62 (-0.16), ALLE: 52.67 (-0.29), AUDC: 4.89 (-0.08), APD: 134.84 (-0.10), DBD: 36.06 (unch), HGG: 5.51 (-0.02), CBM: 23.06 (+0.40), CNSL: 26.01 (+0.01), ATK: 109.51 (+0.68), ANR: 2.70 (-0.21), CI: 101.08 (+2.09), ABC: 87.43 (+0.70), GG: 19.19 (-0.83)

Methode Electronics (MEI) & Greenbrier (GBX): Top Momentum Stocks to Consider - Video Blog
David Bartosiak - Zacks Investment Research - Wed Oct 29, 1:44PM CDT
Methode Electronics (MEI) & Greenbrier, this week’s top momentum stocks, are discussed by Momentum Strategist David Bartosiak.
GBX: 61.09 (+1.18), MEI: 40.10 (+0.51)

Echo Global Logistics (ECHO) Jumps: Stock Rises 9.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 7:57AM CDT
Echo Global Logistics, Inc. (ECHO) was a big mover last session, as the company saw its shares rise nearly 10% on the day.
ECHO: 27.79 (+0.46), GMT: 65.39 (+0.28), GBX: 61.09 (+1.18), CVTI: 22.04 (+0.60)

Regulatory Delay May Not Yet Drag Trinity's Earnings
at Investor's Business Daily - Mon Oct 27, 1:50PM CDT
Railcar makers including Trinity Industries have been on the uptick in recent months as railroads upgrade their equipment to carry more highly flammable crude by rail. How will the possible delay of new regulations along with the falling price of oil...
GBX: 61.09 (+1.18), TRN: 35.85 (+0.15)

GATX Misses on Q3 Earnings, Beats Revenues; Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:00PM CDT
GATX Corporation (GMT) reported third-quarter 2014 adjusted earnings of $1.14 per share, missing the Zacks Consensus Estimate of $1.16.
GMT: 65.39 (+0.28), GBX: 61.09 (+1.18), FLY: 12.61 (-0.15), AYR: 20.22 (+0.03)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...